Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRV1,Adhesion G-protein coupled receptor V1,19065,134,0.72 [0.54-0.96],0.0273356586136925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGBL2,Cytosolic carboxypeptidase 2,19065,134,0.76 [0.67-0.87],8.383283106310296e-05
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19568,141,0.72 [0.54-0.97],0.0277742270887737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY2A,Pancreatic alpha-amylase,21711,162,0.72 [0.53-0.97],0.02974578231544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY2B,Alpha-amylase 2B,21053,155,0.68 [0.50-0.93],0.0148438230234989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APCS,Serum amyloid P-component,19521,135,1.60 [1.00-2.55],0.0489349552020397
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AREG,Amphiregulin,22505,169,1.32 [1.02-1.70],0.0333407500195386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARNT,Aryl hydrocarbon receptor nuclear translocator,22181,166,0.53 [0.34-0.82],0.0048178138417828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASAH2,Neutral ceramidase,22459,168,1.37 [1.03-1.83],0.0297577398270309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1D,V-type proton ATPase subunit D,22505,169,0.51 [0.29-0.89],0.017949798885093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRSK2,Serine/threonine-protein kinase BRSK2,19643,140,0.57 [0.36-0.91],0.0187116120290885
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN1A1,Butyrophilin subfamily 1 member A1,19533,141,0.53 [0.32-0.88],0.0143916835498649
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTNL10,Butyrophilin-like protein 10,18980,139,0.50 [0.29-0.87],0.0143822789531148
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2,Complement C2,22634,169,2.01 [1.04-3.87],0.0375316600775606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLIF,Cobalamin binding intrinsic factor,22575,170,1.23 [1.01-1.48],0.0350872671324291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD109,CD109 antigen,22614,165,0.63 [0.43-0.94],0.0226421295408857
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD164,Sialomucin core protein 24,22614,165,1.50 [1.05-2.14],0.0264983671841017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21796,163,0.78 [0.62-0.98],0.0357960753132409
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRM1,Muscarinic acetylcholine receptor M1,19126,138,0.53 [0.31-0.91],0.0207572820893283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPB2,Carboxypeptidase B2,19659,137,2.20 [1.10-4.38],0.0251233618130276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL12,Stromal cell-derived factor 1,22181,166,0.66 [0.46-0.93],0.0189429682382388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19073,136,0.77 [0.61-0.99],0.0383262003563896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB4A_DEFB4B,Beta-defensin 4A,22301,168,0.90 [0.82-0.99],0.0335423819793677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNM3,Dynamin-3,19643,140,0.71 [0.51-0.99],0.0405226884246102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERMAP,Erythroid membrane-associated protein,19124,135,0.66 [0.45-0.96],0.027937897104398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3B,Protein FAM3B,22505,169,0.70 [0.49-1.00],0.0481223591958165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FASLG,Tumor necrosis factor ligand superfamily member 6,22856,169,0.69 [0.48-0.99],0.0435289110719248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF23,Fibroblast growth factor 23,22776,166,0.69 [0.52-0.91],0.0096485849510264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF6,Fibroblast growth factor 6,19124,135,1.37 [1.07-1.76],0.0142314944586801
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FN1,Fibronectin,19703,139,2.52 [1.42-4.48],0.0015871143395749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19568,141,0.66 [0.46-0.96],0.0300946593151374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAL,Galanin peptides,22709,169,1.25 [1.01-1.54],0.0427107313812662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSAP,Gamma-secretase-activating protein,22099,164,1.23 [1.10-1.37],0.0002068664385158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19643,140,0.61 [0.37-0.99],0.0456995056411075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF1R,Insulin-like growth factor 1 receptor,22505,169,0.41 [0.21-0.81],0.0104413501648221
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12A_IL12B,Interleukin-12,22505,169,0.82 [0.68-0.98],0.030937438544988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1B,Interleukin-1 beta,22081,166,0.76 [0.58-0.99],0.0421996275845544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RA,Interleukin-2 receptor subunit alpha,22437,162,1.54 [1.10-2.16],0.0114755055478612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL31,Interleukin-31,19124,135,0.67 [0.47-0.97],0.0349680503968807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMMT,MICOS complex subunit MIC60,19568,141,0.61 [0.40-0.93],0.0219318955643562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KEL,Kell blood group glycoprotein,22047,163,0.67 [0.46-1.00],0.0474408541960133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIRREL1,Kin of IRRE-like protein 1,19065,134,0.64 [0.42-0.96],0.0316091086042557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIRREL2,Kin of IRRE-like protein 2,22047,163,0.65 [0.46-0.93],0.0188691087141768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIT,Mast/stem cell growth factor receptor Kit,22634,169,1.77 [1.13-2.80],0.013576817626304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK12,Kallikrein-12,22099,164,0.90 [0.82-0.99],0.0301255195208758
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMNB1,Lamin-B1,19530,142,1.26 [1.01-1.57],0.0427053935576752
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19126,138,0.55 [0.34-0.89],0.0141148195523607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDM1,Nuclear protein MDM1,19126,138,0.46 [0.27-0.80],0.0061522551289391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MELTF,Melanotransferrin,19673,140,0.54 [0.31-0.93],0.027682425799786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MICALL2,MICAL-like protein 2,19126,138,0.74 [0.56-0.97],0.0288677896324199
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19643,140,0.70 [0.52-0.93],0.0129788004796234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSLNL,Mesothelin-like protein,19126,138,0.61 [0.38-0.98],0.0417980170309747
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NELL2,Protein kinase C-binding protein NELL2,22709,169,0.49 [0.30-0.81],0.0051486415579023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NME3,Nucleoside diphosphate kinase 3,22642,169,0.48 [0.26-0.88],0.0179463455019772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRP1,Neuropilin-1,22714,169,1.92 [1.20-3.08],0.0062060336155789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSTN,Osteocrin,19126,138,0.51 [0.31-0.86],0.0119720406308609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN2,Prefoldin subunit 2,22047,163,1.26 [1.01-1.58],0.0391470225229098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGA4,Pepsin A-4,19678,139,1.35 [1.07-1.72],0.0131320017616687
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMS1,PMS1 protein homolog 1,19126,138,0.61 [0.42-0.88],0.0085111103936581
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POSTN,Periostin,19669,142,1.55 [1.04-2.31],0.0328056190336282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRC1,Protein regulator of cytokinesis 1,19568,141,1.33 [1.09-1.62],0.0046683319103517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19126,138,0.49 [0.27-0.89],0.0198128779097024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS53,Serine protease 53,19633,140,0.62 [0.40-0.97],0.0349548076908068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTH,Parathyroid hormone,19126,138,0.77 [0.62-0.95],0.0172462047976898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAC3,Ras-related C3 botulinum toxin substrate 3,19126,138,0.70 [0.51-0.97],0.0329401308684767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGMA,Repulsive guidance molecule A,22808,168,0.60 [0.39-0.94],0.025051021961374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPGR,X-linked retinitis pigmentosa GTPase regulator,19126,138,0.59 [0.37-0.94],0.0252260345894009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTBDN,Retbindin,22505,169,0.57 [0.35-0.92],0.0215269923402943
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTKN2,Rhotekin-2,19073,136,0.65 [0.43-0.97],0.0372734905225798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARB1,Scavenger receptor class B member 1,22047,163,1.22 [1.01-1.46],0.0348645397867737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB3A1,Secretoglobin family 3A member 1,19262,139,2.25 [1.17-4.33],0.0152310155706624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA7,Thyroxine-binding globulin,19703,139,2.58 [1.12-5.98],0.0264550341130915
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6,Seizure protein 6 homolog,19126,138,0.45 [0.26-0.80],0.0067514820397023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPD,Pulmonary surfactant-associated protein D,22609,170,1.35 [1.10-1.66],0.0036093395938704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMOC2,SPARC-related modular calcium-binding protein 2,22709,169,0.67 [0.46-0.97],0.0353632618134247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19643,140,0.51 [0.27-0.97],0.0404569195815016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STC2,Stanniocalcin-2,22581,165,2.01 [1.17-3.46],0.0113885010452876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFB2,Transforming growth factor beta-2 proprotein,19568,141,1.30 [1.01-1.67],0.0400125866282673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TJP3,Tight junction protein ZO-3,19065,134,0.59 [0.37-0.94],0.0279041784701386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSC22D1,TSC22 domain family protein 1,19643,140,0.77 [0.59-1.00],0.0467764243429145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTF2,Transcription termination factor 2,19126,138,0.58 [0.41-0.84],0.0037267543266341
